How many 8-K filings has Heartsciences Inc. filed?

Heartsciences Inc. (HSCSW) has 32 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Heartsciences Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Heartsciences Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Heartsciences Inc. (HSCSW) — 8-K Filings

All 8-K filings from Heartsciences Inc.. Browse 32 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (32)

HeartSciences Inc. Files 8-K on Material Agreement — Dec 16, 2025 Risk: medium
HeartSciences Inc. filed an 8-K on December 16, 2025, reporting a material definitive agreement and financial statements. The company, formerly Heart Test Labor
8-K Filing — Dec 15, 2025
8-K Filing — Nov 28, 2025
HeartSciences Inc. Enters Material Definitive Agreement — Oct 1, 2025 Risk: medium
On September 26, 2025, HeartSciences Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as H
HeartSciences Inc. Faces Delisting Concerns — Sep 17, 2025 Risk: high
HeartSciences Inc. filed an 8-K on September 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company,
HeartSciences Inc. Files 8-K with Financials and Other Events — Sep 8, 2025 Risk: low
HeartSciences Inc. filed an 8-K on September 8, 2025, reporting events as of September 5, 2025. The filing includes information on financial statements and exhi
HeartSciences Inc. Files 8-K Report — Aug 22, 2025 Risk: low
On August 22, 2025, HeartSciences Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 550 Reserve Street, Su
HeartSciences Inc. Files 8-K: Material Agreement & Financials — Aug 4, 2025 Risk: medium
HeartSciences Inc. filed an 8-K on August 4, 2025, reporting a material definitive agreement and financial statements. The filing pertains to the company's oper
HeartSciences Inc. Files 8-K for Other Events — Jul 30, 2025 Risk: low
HeartSciences Inc. filed an 8-K on July 30, 2025, reporting an event that occurred on July 25, 2025. The filing pertains to "Other Events" and "Financial Statem
HeartSciences Inc. Raises $1.5M via Stock and Warrant Offering — Jul 21, 2025 Risk: medium
HeartSciences Inc. announced on July 16, 2025, that it has entered into a securities purchase agreement. The company plans to issue and sell approximately $1.5
HeartSciences Inc. Files 8-K: Material Agreement & Officer Changes — Jul 14, 2025 Risk: medium
HeartSciences Inc. announced on July 9, 2025, the entry into a material definitive agreement and changes in its board of directors and officer compensation. The
HeartSciences Inc. Files 8-K with Bylaw Amendments — Jul 1, 2025 Risk: low
HeartSciences Inc. filed an 8-K on June 27, 2025, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements and exhibits.
HeartSciences Inc. Files 8-K with Material Agreements — Jun 4, 2025 Risk: medium
HeartSciences Inc. filed an 8-K on May 28, 2025, reporting the entry into a material definitive agreement, amendments to its articles of incorporation or bylaws
HeartSciences Inc. Raises $1.5M via Stock and Warrant Sale — Jun 3, 2025 Risk: medium
HeartSciences Inc. announced on June 3, 2025, that it has entered into a securities purchase agreement. The company plans to issue and sell approximately $1.5 m
HeartSciences Inc. Amends Corporate Documents — May 28, 2025 Risk: low
HeartSciences Inc. filed an 8-K on May 28, 2025, reporting an amendment to its articles of incorporation or bylaws, effective May 21, 2025. The company, previou
HeartSciences Inc. Faces Delisting Concerns — May 19, 2025 Risk: high
HeartSciences Inc. filed an 8-K on May 19, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also reporting
HeartSciences Faces Delisting Concerns — Mar 21, 2025 Risk: high
HeartSciences Inc. filed an 8-K on March 21, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of March 19, 20
HeartSciences Inc. Reports Equity Sales & Officer Changes — Jan 21, 2025 Risk: medium
HeartSciences Inc. filed an 8-K on January 21, 2025, reporting on unregistered sales of equity securities and changes in directors and officers. The filing also
HeartSciences Inc. Files 8-K with Office Location — Dec 17, 2024 Risk: low
On December 17, 2024, HeartSciences Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 550 Reserve Street,
HeartSciences Inc. Files 8-K on Shareholder Vote Matters — Nov 8, 2024 Risk: medium
HeartSciences Inc. filed an 8-K on November 8, 2024, reporting on a submission of matters to a vote of security holders that occurred on November 7, 2024. The c
Heart Test Labs Files 8-K with Corporate Updates — Oct 18, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on October 18, 2024, reporting events as of October 11, 2024. The filing indicates amendments to its Articles of Inco
Heart Test Labs Files 8-K on Definitive Agreement — Sep 10, 2024 Risk: medium
Heart Test Laboratories, Inc. entered into a Material Definitive Agreement on September 6, 2024, related to the unregistered sale of equity securities. The fili
Heart Test Labs Enters Material Agreement, Modifies Security Holder Rights — Aug 21, 2024 Risk: medium
Heart Test Laboratories, Inc. announced on August 19, 2024, that it entered into a material definitive agreement related to warrants. The company also reported
Heart Test Labs Files 8-K on Operations — Jul 29, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on July 29, 2024, reporting on its results of operations and financial condition, as well as financial statements and
Heart Test Labs Files 8-K — Jun 4, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on June 4, 2024, reporting an event that occurred on June 3, 2024. The filing indicates the company is incorporated i
Heart Test Labs Files 8-K for Financials — May 22, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on May 22, 2024, reporting events as of May 16, 2024. The filing primarily concerns financial statements and exhibits
Heart Test Labs Files 8-K on Security Holder Rights — May 15, 2024 Risk: medium
Heart Test Laboratories, Inc. filed an 8-K on May 15, 2024, to report material modifications to the rights of its security holders and amendments to its article
Heart Test Labs Delisted from Nasdaq — May 10, 2024 Risk: high
Heart Test Laboratories, Inc. filed an 8-K on May 10, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's common
Heart Test Labs Files 8-K on Operations and Financials — Mar 14, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on March 14, 2024, reporting on its results of operations and financial condition, as well as financial statements an
Heart Test Labs Files 8-K on Shareholder Vote & Exhibits — Feb 15, 2024 Risk: low
Heart Test Laboratories, Inc. filed an 8-K on February 15, 2024, reporting the submission of matters to a vote of security holders and the filing of financial s
Heart Test Labs (HSCS) Delisted from Nasdaq on Jan 30 — Jan 31, 2024
Heart Test Laboratories, Inc. (HSCS) announced on January 30, 2024, that its common stock (HSCS) and warrants (HSCSW) will be delisted from The Nasdaq Stock Mar
Heart Test Labs Common Stock & Warrants Now Trading on Nasdaq — Jan 25, 2024
Heart Test Laboratories, Inc. (HSCS) announced on January 22, 2024, that its Common Stock and Warrants are now registered on The Nasdaq Stock Market LLC under t

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX